Skip to main content
. 2020 Aug 13;2020:3928504. doi: 10.1155/2020/3928504

Figure 1.

Figure 1

Differences in concentrations of IL-17A, IL-17F, and TNF-α between patients with head and neck cancer at different stages of disease. (a) There was a significant difference in salivary concentration of IL-17A (p < 0.001) between patients with different disease stage, and post hoc tests showed significant differences between stage I/II patients as well as stage III and stage IV patients. (b) There was a significant difference in salivary concentration of IL-17F (p < 0.01) between stages, and post hoc tests showed significant differences between stage I/II patients as well as stage IV patients and stage III patients. (c) There was a significant difference in salivary concentration of TNF-α (p < 0.01) between stages, and post hoc tests showed significant differences between stage I/II patients and stage IV patients. ∗p < 0.05, ∗∗∗p < 0.001, _median.